Israel Englander Eiger Bio Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.21 - $0.43 $48,017 - $98,322	-228,657 Reduced 73.81%	81,144 $17,000
Q2 2023 Aug 14, 2023	BUY	$0.55 - $1.26 $162,796 - $372,951	295,993 Added 2143.63%	309,801 $216,000
Q1 2023 May 15, 2023	SELL	$0.89 - $2.52 $670,448 - $1.9 Million	-753,313 Reduced 98.2%	13,808 $12,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $782,463 - $5.74 Million	767,121 New	767,121 $905,000
Q4 2021 Feb 14, 2022	SELL	$5.12 - $8.19 $88,683 - $141,858	-17,321 Closed	0 $0

Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $115,704 - $157,621	17,321 New	17,321 $116,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $9.23 $1.05 Million - $1.24 Million	-134,865 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $157,633 - $236,450	-18,677 Reduced 12.16%	134,865 $1.19 Million
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $1.23 Million - $1.89 Million	153,542 New	153,542 $1.89 Million
Q2 2020 Aug 14, 2020	SELL	$5.4 - $13.37 $69,541 - $172,178	-12,878 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$4.91 - $14.7 $48,329 - $144,692	-9,843 Reduced 43.32%	12,878 $88,000
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $221,984 - $355,810	22,721 New	22,721 $339,000
Q2 2019 Aug 14, 2019	SELL	$9.54 - $14.96 $2.03 Million - $3.18 Million	-212,430 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$10.31 - $14.38 $1.93 Million - $2.69 Million	187,358 Added 747.28%	212,430 $2.97 Million
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $216,371 - $310,892	25,072 New	25,072 $255,000
Q3 2018 Nov 14, 2018	SELL	$9.6 - $12.9 $685,161 - $920,685	-71,371 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $592,379 - $1.2 Million	71,371 New	71,371 $871,000
Q1 2018 May 15, 2018	SELL	$8.1 - $16.0 $301,846 - $596,240	-37,265 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$10.5 - $14.15 $133,686 - $180,157	-12,732 Reduced 25.47%	37,265 $520,000
Q3 2017 Nov 14, 2017	BUY	$7.7 - $11.55 $384,976 - $577,465	49,997	49,997 $550,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $556M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account